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This study was conducted to determine the recent level of contamination with Fumonisin B1 (FB1) and Fumonisin 
B2 (FB2) in major medicinal plants and to assess consumer exposure in  northern Turkey. FB1 and FB2 were 
investigated by using high performance liquid chromatography (HPLC) with fl uorescence detection after 
derivatization with o-phthaldialdehyde (OPA). A total of 78 homemade medicinal plant samples from 14 species 
were analysed. The recovery in thyme was 67.2±5.2% for FB1 and 80.8±14.3% for FB2 spiked with 1 μg g
–1 of each 
analyte. The minimum detectable amount for the OPA derivatives of FB1 and FB2 were 1 ng per injection and 2.5 ng 
per injection, respectively. The limit of quantitation (LOQ) S/N=10 was 0.078 and 0.313 μg g–1, and the limit of 
detection (LOD) S/N=3 was 0.023 and 0.093 μg g–1 for FB1 and FB2, respectively. FB1 was detected in thyme 
(0.125) and mint (0.125 and 0.256 μg g–1) samples; however. FB2 toxin was below the detection limit in all samples. 
These results indicate that toxins might be present in homemade medicinal plants; however, the risk of exposure to 
fumonisins by the consumption of those plants was lower than the estimated TDI limits (<2 μg kg–1 bw).
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Fumonisins [Fumonisin B1 (FB1) and Fumonisin B2 (FB2)] are secondary metabolites 
produced by several species of the Fusarium, which include Fusarium verticillioides (Sacc.), 
Nirenberg (ex F. moniliforme Sheldon) and Fusarium proliferatum. They are associated with 
maize and are frequently present in naturally contaminated corn, feeds, medicinal and other 
plants throughout the world; particularly where a high humidity exists (CASTELO et al., 1998; 
MARTINS et al., 2001a; SOLFRIZZO et al., 2001; OMURTAG, 2001; OMURTAG & YAZICIOĞLU, 2004).
Fumonisin was fi rst isolated from maize that caused poisoning in the Transkei in South 
Africa in 1988 (BEZUIDENHOUT et al., 1988), and thereafter Fusarium sp. was also detected in 
corn silk (MARTINS et al. 2001b) and herbal teas with highest quantity in sage (BOKHARI & 
ALY, 2013). Moisture content during harvesting and postharvest process of corn are critical 
to control fungal growth and further fumonisin production (TRUCKSESS et al., 2000; ONO et al., 
2002). Studies on the presence of FB1 conducted in 18 countries revealed a high frequency 
(93%) in maize samples (DE NIJS et al., 1998). Except ‘extrusion cooking’ in cereal industry, 
FB1 cannot be destroyed by cooking and could therefore enter the human food chain (ALBERTS 
et al., 1990; CASTELLS et al., 2005).
Despite the diffi culty of determining the effects of fumonisins on humans, most of the 
studies agreed on that consumption of corn and cereal products contaminated with FB1 may 
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contribute to esophageal cancer (CHU & LI, 1994; PIÑEIRO et al., 1997). However, medicinal 
plants and several food supplements might also bear the risk of contamination (WANG et al., 
2000; DI MAVUNGU et al., 2009; ALIZADEH et al., 2012; BRYLA et al., 2013). High levels of 
fumonisins were also recorded in animal feeds associated with confi rmed fi eld outbreaks, i.e. 
pulmonary oedema (PE) in pig (COLVIN et al., 1993) and induced leukoencephalomalacia 
(LEM) in horses (KELLERMAN et al., 1990). Hence FB1 is mentioned as potentially carcinogenic 
to humans (class 2B carcinogens) (IARC, 2002) and together with other mycotoxins is 
considered as a cancer inducer in humans (CHU & LI, 1994).
Despite the increased consumption of medicinal plants, researches on their level of 
fumonisin are rare compared to that in corn. In our consideration, among the instrumental 
methods developed for the analytical determination of the fumonisins, high-performance 
liquid chromatography (HPLC) is one of the most widely used with reliable results. Therefore, 
the purpose of this study was to investigate the level of natural contamination of FB1 and FB2 
by HPLC in several home-grown medicinal plants, which are most frequently consumed for 
medicinal and also dietary purposes in Turkey. All of the collected samples (n=78) originated 
from the northern Anatolia, where mean relative humidity is 77% (SAHIN & CIGIZOGLU, 2012).
1. Materials and methods
Seventy-eight medicinal plants were collected from Ordu, which is a city in the middle region 
of the Black Sea shore of Turkey, in-between May and July. Leaves of mint (Mentha piperita), 
laurel (Laurus nobilis), stinging nettle (Urtica sp.), thyme (Oryganum sp.), and basil (Ocimum 
basilicum) leaves; fl owers of lime (Tilia sp.), chamomile (Anthemis sp.), corn-poppy (Papaver 
rhoeas), and marshmallow (Althea offi cinalis); herba of horsetail (Equisetum arvense) and 
St. John’s wort (Hypericum perforatum); fruit of rose hip (Rosa sp.), raspberry (Rubus 
sanctus), and coriander (Coriandrum sativum) were dried under shade and studied to evaluate 
the presence of FB1 and FB2. Analyses were carried out with regard to the reported HPLC 
method after OMURTAG and YAZICIOĞLU (2004) as given below.
1.1. Chemicals
The FB1 and FB2 standards (F 1147) and (F 3771), respectively, were supplied from Sigma. 
All chemicals were the products of Sigma, Merck, and JT Baker and all of the solvents were 
of HPLC grade. Standards, solutions, and mobile phase were prepared in HPLC-grade water 
obtained from Millipore-Milli Q-RG. Isocratic conditions were applied in the HPLC 
analytical method.
1.2. Preparation of stock solutions
The standard stock solutions of FB1 and FB2 were separately dissolved in the mixture of 
acetonitrile and water (1:1, v/v) as 250 μg ml–1. From this solution 50 μg ml–1 were prepared 
for each FB1 and FB2 standard stock solutions. All stock solutions were sealed and stored at 
–20 °C until use.
1.3. Preparation of sample
A sample of 25 g was placed in a Waring blender and extracted with 125 ml of a mixture of 
methanol and water (3:1, v/v) for 5 min and then fi ltered through Whatman No. 4 fi lter paper. 
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The pH of the extract was adjusted when necessary to pH 5.8–6.5 with 1 M NaOH. A 1 ml 
portion containing 0.2 g sample was applied to a 1 ml SAX (strong anion exchange, Supelco, 
Part number SP1984A, sorbent quantity is 100 mg) solid phase extraction column (SPE) 
previously conditioned with 2 ml methanol followed by 1 ml water at a fl ow rate ≤2 ml 
min–1 with a manifold (Alltech- 210224, 21212). The column was washed successively with 
500 μl water and 500 μl methanol. All washes were discarded. FB1 and FB2 were eluted with 
1 ml methanol/acetic acid (99:1, v/v) at a fl ow rate ≤1 ml min–1. The eluate equivalent to 0.2 
g sample was evaporated to dryness under a stream of nitrogen in a water bath at 60 °C.
1.4. Apparatus
The HPLC (Agilent 1100 Series, USA) was a combination of a Model G1311A Quaternary 
Pump with a Model G1321A Fluorescence Detector. The fl uorescence was recorded at 
excitation (λEx) and emission (λEm) wavelengths of 335 and 455 nm, respectively. The 
sample loop was 20 μl (Rheodyne 7725i, USA). The column heater was thermostatted 
column compartment with a Model G1316A. A reverse phase Symmetry C18 column was 
used (4.6×250 mm, 5 μm particle size, part no: WAT054275) (Waters) with a guard column 
(Hicrom KR100-5C18-10C, 10 mm length). Data was processed through the 
AgilentChemStation (USA).
1.5. Operating conditions
The mobile phase was methanol/0.1 M sodium dihydrogen phosphate (8:2, v/v), adjusted to 
apparent pH: 3.33 with o-phosphoric acid. The mobile phase fi ltered through a Millex HV 
Millipore (0.45 μm) fi lter, degassed by Agilent 1100 Series (Model G1379A). The fl ow rate 
was 0.7 ml min–1. The column temperature was 25 °C. The standard curves of FB1 (tR=10.5 
min) and FB2 (tR=22.5 min) were linear between the ranges of 1–40 ng and 2.5–40 ng, 
respectively. FB1 plot linear regression line was y=3.2027x+0.1552 (r=0.9998) and FB2 plot 
linear regression line was y=1.3057x–0.7791 (r=0.9995).
1.6. Procedure for HPLC
The residue was fi rst dissolved in 200 μl of methanol and 50 μl of this solution was derivatized 
by addition of 200 μl o-phthaldialdehyde (OPA) reagent (40 mg of OPA was dissolved in 1 
ml methanol and diluted with 5 ml 0.1 M disodium tetraborate solution, then 50 μl of 
2-mercaptoethanol was added to this solution and mixed). OPA solution was prepared daily 
and stored at room temperature in capped amber vial. The fi nal extracts were 0.2 g ml–1 
equivalent sample concentrations, and 20 μl (4 mg sample equivalent) of the extracts were 
injected into HPLC within 1 min of derivatization. For the HPLC quantitation, the samples 
were injected into the HPLC system under the same conditions as used for preparing 
calibration graphs and were analysed in triplicate.
2. Results and discussion
In this study, 78 homemade medicinal plants were collected from northern Turkey. FB1 was 
detected in three samples (0.125, 0.125, and 0.256 μg g–1), however, FB2 was detected in 
none.
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Table 1. Results of HPLC method for FB1 and FB2 in 78 medicinal plant samples that are especially consumed in 
north Anatolia (Black Sea region in Turkey)
Medicinal plants (Positive/Total) Conc. (μg g–1)
FB1 FB2 FB1 FB2
Laurel (Laurus nobilis) 0/1 0/1 nd nd
Horsetail (Equisetum sp.) 0/1 0/1 nd nd
Basil (Ocimum basilicum) 0/5 0/5 nd nd
Mint (Mentha sp.) 2/15 0/15 0.125
0.256
nd
Thyme (Thymus sp.) 1/14 0/14 0.125 nd
Lime (Tilia sp.) 0/8 0/8 nd nd
Coriander (Coriandrum sativum) 0/8 0/8 nd nd
Nettle (Urtica dioica) 0/7 0/7 nd nd
Rosehip (Rosa canina) 0/9 0/9 nd nd
Poppy (Papaver rhoeas) 0/3 0/3 nd nd
Marshmallow (Althea offi cinalis) 0/3 0/3 nd nd
Raspberry (Rubus sp.) 0/2 0/2 nd nd
St. John’s Wort (Hypericum perforatum) 0/1 0/1 nd nd
Walnut leaves (Juglandis folium) 0/1 0/1 nd nd
nd: not detected
The mean recovery results of the analysed fi ve replicates with 1 μg g–1 FB1 and FB2 for 
thyme, mint, and stinging nettle are given in Table 2.
Table 2. Recovery results of fumonisins from thyme, mint, and stinging nettle
Sample (n=5) Concentration added (μg g–1) Recovery (%)
FB1 FB2 FB1 FB2
Thyme 1 1 67.2 ±5.2 80.8 ±14.3
Mint 1 1 62.1 ±7.9 80.4 ±7.9
Stinging nettle 1 1 85.9 ±3 89.2 ±10.8
The minimum detectable amount for the OPA derivatives of FB1 and FB2 were 1 ng per 
injection and 2.5 ng per injection, respectively. The limit of quantitation (LOQ) S/N=10 was 
0.078 and 0.313 μg g–1 for FB1 and FB2, respectively. The limit of detection (LOD) S/N=3 
was 0.023 and 0.093 μg g–1 for FB1 and FB2, respectively.
The levels of fumonisin contamination in feed, corn, and corn-based products range 
between 0.25 μg g–1 and 188±25.38 μg g-1 generally in the country (SONAL & ORUÇ, 2000; 
OMURTAG, 2001; OCAK & BOSTAN, 2010). Analyses in corn fl our conducted in the northern 
region of Turkey pointed out that processing of corn is critical in the decontamination from 
Fusarium toxin (NUMANOGLU et al., 2010). However, out of the large number of researches 
conducted to detect the level of fumonisin in corn and cereals, a few are studied in plants that 
are used with medicinal and dietary purpose. In Turkey, OMURTAG and YAZICIOĞLU (2004) 
detected FB1 in mint and stinging nettle (0.160 and 1.487 μg g
–1) from herbal tea and medicinal 
plant samples. Besides, the fi rst report in Portugal on the natural and frequent occurrence of 
FB1 in medicinal plants prevised the need of risk management strategies on the natural 
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contamination with this mycotoxin (MARTINS et al., 2001a). In Eastern Cape Province of 
South Africa, levels of FB1 was in the range of 34–524 μg kg
–1 and 8–1553 μg kg–1 in several 
dietary and medicinal plants, respectively (SEWRAM et al., 2006).
The medicinal and dietary plants consumed all over the world have an important role in 
human health. The current incidence and the data available on the toxicity and carcinogenicity 
of FB1 and FB2 indicate that the mycotoxins are a potential risk to human health and their 
occurrence is also harmful to economy. Surveys conducted in many countries have shown 
that contamination of food by Fusarium species of fungi is a major problem, because growth, 
depending on the climate conditions, can develop in the fi eld and during storage. Therefore, 
they need to be controlled and analysed all throughout the processing stage and not only for 
FB1 and FB2 but also for other Fusarium mycotoxins. In this context, a guideline on FB1 and 
FB2 in maize and maize products is set in Turkish Food Codex (TGK, 2011), however a 
specifi ed limit for fumonisins in plants used as food supplement is currently not available.
The Swiss Federal Offi ce of Public Health has established regulations for FB1 and FB2 
in maize products at 1 μg g–1 (FAO, 1997; SWISS FEDERAL OFFICE OF PUBLIC HEALTH, 1997) 
and a Tolerable Daily Intake (TDI) value is estimated by the Joint Food and Agriculture 
Organization-World Health Organization Expert Committee as 2 μg kg–1 bw (WHO, 2000). 
The European Commission also highlighted this mentioned TDI limit for Fusarium toxins in 
the recent Commission Regulation (EC, 2007). There is evidence that epidemiological studies 
evaluate the intake of FB1 in diet as a risk factor to increase the rate of human oesophageal 
cancer, liver damage, and levels of certain classes of lipids, especially sphingolipids (NJOBEH 
et al., 2010). Additionally, the intake of high levels of fumonisin during early pregnancy was 
associated with the risk to neural tube defects of the brain and spinal cord (GELINEAU-VAN 
WAES et al., 2005; MISSMER et al., 2006).
For this purpose, to estimate the dietary exposure to fumonisin via consumption of 
contaminated medicinal plants in northern region of Turkey, a simple risk assessment scenario 
was realized on mint, which was the highest contaminated plant in our study with a mean of 
0.191 μg g–1 of the two positive samples. TDI of 2 μg kg–1 bw per day is considered for an 
adult person of 70 kg (=140 μg per day), inspired by the similar assessment of DI MAVUNGU 
and co-workers (2009) conducted for ochratoxin A. We supposed that dried mint is widely 
used in most of the traditional dishes in Turkey and its approximately ratio is one dessert 
spoon per portion (~2 g mint). Thus, an adult person of 70 kg would consume 0.382 μg, 
which might be accepted as a tolerable dose (<140 μg per day).
Consequently, increase or decrease of these toxins in foods depend on how the production 
line and method operates. Accordingly, we assume that drying plant without using standardized 
methods might increase the risk of unwanted mycotoxins entering the food chain.
3. Conclusions
In conclusion, on the presence of fumonisin little is known about homemade medicinal 
plants. In our study, regular consumption of low doses was not considered, but detected level 
of contamination did not bear a relevant risk. Hence, for monitoring the occurrence of FB1 
and FB2 in those plants, more fi eld studies on the preparation steps are needed.
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